Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis.
OBJECTIVE
To investigate the cellular mechanism of bone destruction in collagen-induced arthritis (CIA).


METHODS
After induction of CIA in DA rats, a histologic study of the advanced arthritic lesion was carried out on whole, decalcified joints from the hindpaws of affected animals. To conclusively identify osteoclasts, joint tissue sections were stained for tartrate-resistant acid phosphatase (TRAP) enzyme activity, and calcitonin receptors (CTR) were identified using a specific rabbit polyclonal antibody. The expression of messenger RNA (mRNA) for the osteoclast differentiation factor (also known as receptor activator of nuclear factor kappaB ligand [RANKL]) was investigated using in situ hybridization with a specific riboprobe.


RESULTS
TRAP-positive and CTR-positive multinucleated cells were invariably detected in arthritic lesions that were characterized by bone destruction. Osteoclasts were identified at the pannus-bone and pannus-subchondral bone junctions of arthritic joints, where they formed erosive pits in the bone. TRAP-positive multinucleated cells were detected within synovium and at the bone erosive front; however, CTR-positive multinucleated cells were present only at sites adjacent to bone. RANKL mRNA was highly expressed in the synovial cell infiltrate in arthritic joints, as well as by osteoclasts at sites of bone erosion.


CONCLUSIONS
Focal bone erosion in CIA is attributed to cells expressing definitive features of osteoclasts, including CTR. The expression of RANKL by cells within inflamed synovium suggests a mechanism for osteoclast differentiation and activation at sites of bone erosion. Inhibitors of RANKL may represent a novel approach to treatment of bone loss in rheumatoid arthritis.
Romas
E
E
Department of Medicine, University of Melbourne, St. Vincent's Hospital, and St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Bakharevski
O
O
Hards
D K
DK
Kartsogiannis
V
V
Quinn
J M
JM
Ryan
P F
PF
Martin
T J
TJ
Gillespie
M T
MT
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000139:chemically induced / Q000378:metabolism*; D015415:Biomarkers / Q000032:analysis; D001847:Bone Diseases / Q000378:metabolism*; D002352:Carrier Proteins / Q000096:biosynthesis*; D003094:Collagen / Q000276:immunology; D004195:Disease Models, Animal; D005260:Female; D006651:Histocytochemistry; D017403:In Situ Hybridization; D007527:Isoenzymes / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D053245:RANK Ligand; D051381:Rats; D018003:Receptors, Calcitonin / Q000096:biosynthesis; D000071681:Tartrate-Resistant Acid Phosphatase
D015415:Biomarkers; D002352:Carrier Proteins; D007527:Isoenzymes; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D018003:Receptors, Calcitonin; D003094:Collagen; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase